Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

17-Alpha-Hydroxyprogesterone Caproate for Reduction of Neonatal Morbidity Due to Preterm Birth in Twin and Triplet Pregnancies - A Concurrent Randomized Double-blinded Clinical Trial

NCT00163020 is registered in ClinicalTrials.gov with Obstetrix Medical Group as lead sponsor.

NCT NCT00163020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00163020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
17-Alpha-Hydroxyprogesterone Caproate for Reduction of Neonatal Morbidity Due to Preterm Birth in Twin and Triplet Pregnancies - A Concurrent Randomized Double-blinded Clinical Trial
Lead sponsor
Obstetrix Medical Group
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2004
Completion date
August 31, 2009
Enrollment
321 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

preterm birth